Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in We're just asking for data- double-blinded, placebo-controlled clinical trials
It may provide anti-inflammatory and antioxidant effects
(Study: Heffernan et al., 2001) Administration: AOD 9604 is typically administered through subcutaneous injections, with ongoing investigations into potential oral formulations for enhanced patient convenience
If authorization wasnt actually required, youve got strong grounds for appeal
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
US$ 28.29
US$ 26.78
US$ 28.48
US$ 28.46
US$ 28.87
